rs144629123
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_130468.4(CHST14):āc.635T>Cā(p.Val212Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000322 in 1,613,726 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_130468.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152142Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000538 AC: 135AN: 251156Hom.: 2 AF XY: 0.000478 AC XY: 65AN XY: 135854
GnomAD4 exome AF: 0.000311 AC: 455AN: 1461584Hom.: 1 Cov.: 32 AF XY: 0.000347 AC XY: 252AN XY: 727092
GnomAD4 genome AF: 0.000427 AC: 65AN: 152142Hom.: 1 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Variant summary: CHST14 c.635T>C (p.Val212Ala) results in a non-conservative amino acid change located in the Sulfotransferase family (IPR005331) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00032 in 1613726 control chromosomes, predominantly at a frequency of 0.0062 within the Ashkenazi Jewish subpopulation in the gnomAD database (v4), including 2 homozygotes. The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 5.55 fold of the estimated maximal expected allele frequency for a pathogenic variant in CHST14 causing Ehlers-Danlos syndrome, musculocontractural type phenotype (0.0011). To our knowledge, no occurrence of c.635T>C in individuals affected with Ehlers-Danlos syndrome, musculocontractural type and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 373593). Based on the evidence outlined above, the variant was classified as benign. -
A variant of uncertain significance has been identified in the CHST14 gene. The V212A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The V212A substitution occurs at a position that is conserved through mammals, and alanine (A) is not wild type in any species. In addition, in silico analysis predicts this variant is probably damaging to the protein structure/function. Nonetheless, V212A is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Finally, this variant has been reported in approximately 0.1-0.2% of alleles from individuals of European ancestry in the NHLBI Exome Sequencing Project and the Exome Aggregation Consortium (ExAC), including three homozygous individuals. -
Ehlers-Danlos syndrome Uncertain:1
- -
not provided Benign:1
CHST14: PP3, BS2 -
Ehlers-Danlos syndrome, musculocontractural type Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at